Invention Grant
![Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors](/docs/US/2019-09-03/US10398699B2/abs.jpg.600x600.jpg)
- Patent Title: Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
-
Application No.: US15960069Application Date: 2018-04-23
-
Publication No.: US10398699B2Publication Date: 2019-09-03
- Inventor: James D. Rodgers , Stacey Shepard
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P35/04 ; C07D487/04 ; C07D471/04 ; A61K45/06 ; C07D417/04 ; C07B59/00 ; A61K9/00 ; A61K9/20 ; A61K31/573
![Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors](/abs-image/US/2019/09/03/US10398699B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Public/Granted literature
- US20180338978A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS Public/Granted day:2018-11-29
Information query
IPC分类:
